{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:35:30Z","timestamp":1793018130272,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06299-7","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:57:26Z","timestamp":1789963046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Attitudes toward dermocosmetic and aesthetic procedures in patients with systemic sclerosis: a cross-sectional survey"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-1139","authenticated-orcid":false,"given":"Fatma","family":"Basibuyuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-0591","authenticated-orcid":false,"given":"Tuba Demirci","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5118-9307","authenticated-orcid":false,"given":"A. Merih","family":"Birlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"6299_CR1","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O et al (2015) Systemic sclerosis. Nat Rev Dis Primers 1:15002. https:\/\/doi.org\/10.1038\/nrdp.2015.2","journal-title":"Nat Rev Dis Primers"},{"key":"6299_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685\u20131699. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"},{"key":"6299_CR3","doi-asserted-by":"publisher","first-page":"152593","DOI":"10.1016\/j.semarthrit.2024.152593","volume":"70","author":"A Anilkumar","year":"2025","unstructured":"Anilkumar A, Wells M, Domsic RT et al (2025) The pathogenesis, diagnostic utility and clinical relevance of cutaneous telangiectasia in systemic sclerosis. Semin Arthritis Rheum 70:152593. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152593","journal-title":"Semin Arthritis Rheum"},{"key":"6299_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bodyim.2006.11.002","volume":"4","author":"LJ Heinberg","year":"2007","unstructured":"Heinberg LJ, Kudel I, White B et al (2007) Assessing body image in patients with systemic sclerosis (scleroderma): validation of the Adapted Satisfaction with Appearance Scale. Body Image 4:79\u201386. https:\/\/doi.org\/10.1016\/j.bodyim.2006.11.002","journal-title":"Body Image"},{"key":"6299_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/acr.20307","volume":"62","author":"LR Jewett","year":"2010","unstructured":"Jewett LR, Hudson M, Haythornthwaite JA et al (2010) Development and validation of the Brief Satisfaction with Appearance Scale for systemic sclerosis. Arthritis Care Res (Hoboken) 62:1779\u20131786. https:\/\/doi.org\/10.1002\/acr.20307","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6299_CR6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/annrheumdis-2016-210534","volume":"76","author":"A Man","year":"2017","unstructured":"Man A, Correa JK, Ziemek J et al (2017) Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis. Ann Rheum Dis 76:1374\u20131380. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210534","journal-title":"Ann Rheum Dis"},{"key":"6299_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-026-01168-0","author":"\u00c1 \u00c1goston-Szab\u00f3","year":"2026","unstructured":"\u00c1goston-Szab\u00f3 \u00c1, Szab\u00f3 A, Pytel P et al (2026) Adaptation and validation of the brief-satisfaction with appearance scale into Hungarian for patients with systemic sclerosis. J Patient Rep Outcomes. https:\/\/doi.org\/10.1186\/s41687-026-01168-0","journal-title":"J Patient Rep Outcomes"},{"key":"6299_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/23971983241285212","volume":"10","author":"M Orlandi","year":"2025","unstructured":"Orlandi M, Spinella A, De Pinto M et al (2025) The importance of body image and aesthetic medicine in systemic sclerosis. J Scleroderma Relat Disord 10:3\u20136. https:\/\/doi.org\/10.1177\/23971983241285212","journal-title":"J Scleroderma Relat Disord"},{"key":"6299_CR9","doi-asserted-by":"publisher","first-page":"NP25","DOI":"10.1093\/asj\/sjae200","volume":"45","author":"A Almadori","year":"2025","unstructured":"Almadori A, Fung SC, Denton CP, Butler PEM (2025) Fat grafting and adipose stem cells for facial systemic sclerosis: a systematic review of the literature. Aesthet Surg J 45:NP25\u2013NP30. https:\/\/doi.org\/10.1093\/asj\/sjae200","journal-title":"Aesthet Surg J"},{"key":"6299_CR10","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.55563\/clinexprheumatol\/ycy3k7","volume":"41","author":"Y Cao","year":"2023","unstructured":"Cao Y, Kan H, Ma X et al (2023) Autologous fat or adipose-derived stem cell grafting in systemic sclerosis treatment: a systematic review and meta-analysis. Clin Exp Rheumatol 41:1659\u20131669. https:\/\/doi.org\/10.55563\/clinexprheumatol\/ycy3k7","journal-title":"Clin Exp Rheumatol"},{"key":"6299_CR11","doi-asserted-by":"publisher","first-page":"104009","DOI":"10.1016\/j.autrev.2026.104009","volume":"25","author":"A Gkouvi","year":"2026","unstructured":"Gkouvi A, Liapis NM, Zafiriou E et al (2026) Hyaluronic acid fillers in systemic sclerosis and localized scleroderma: a systematic review. Autoimmun Rev 25:104009. https:\/\/doi.org\/10.1016\/j.autrev.2026.104009","journal-title":"Autoimmun Rev"},{"key":"6299_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10103-026-04799-3","volume":"41","author":"A Jafarzadeh","year":"2026","unstructured":"Jafarzadeh A, Leisi A, Goodarzi A (2026) A systematic review of therapeutic procedures for the treatment of morphea and systemic sclerosis. Lasers Med Sci 41:34. https:\/\/doi.org\/10.1007\/s10103-026-04799-3","journal-title":"Lasers Med Sci"},{"key":"6299_CR13","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F n den Hoogen","year":"2013","unstructured":"n den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"6299_CR14","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.3346\/jkms.2023.38.e403","volume":"38","author":"O Zimba","year":"2023","unstructured":"Zimba O, Gasparyan AY (2023) Designing, conducting, and reporting survey studies: a primer for researchers. J Korean Med Sci 38:e403. https:\/\/doi.org\/10.3346\/jkms.2023.38.e403","journal-title":"J Korean Med Sci"},{"key":"6299_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/23971983251326746","volume":"10","author":"J Langleben","year":"2025","unstructured":"Langleben J, Dal Santo T, Golberg M et al (2025) Comparison of appearance dissatisfaction and appearance-related social discomfort among people with systemic sclerosis and burn injury. J Scleroderma Relat Disord 10:530\u2013539. https:\/\/doi.org\/10.1177\/23971983251326746","journal-title":"J Scleroderma Relat Disord"},{"key":"6299_CR16","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1007\/s00296-011-2230-2","volume":"32","author":"FI Cinar","year":"2012","unstructured":"Cinar FI, Unver V, Yilmaz S et al (2012) Living with scleroderma: patients\u2019 perspectives, a phenomenological study. Rheumatol Int 32:3573\u20133579. https:\/\/doi.org\/10.1007\/s00296-011-2230-2","journal-title":"Rheumatol Int"},{"key":"6299_CR17","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1007\/s00296-024-05745-8","volume":"44","author":"T Demirci Yildirim","year":"2024","unstructured":"Demirci Yildirim T, Basibuyuk F, Birlik AM (2024) Patients with systemic sclerosis frequently use phytopharmaceuticals: a cross-sectional survey. Rheumatol Int 44:3079\u20133085. https:\/\/doi.org\/10.1007\/s00296-024-05745-8","journal-title":"Rheumatol Int"},{"key":"6299_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00296-025-06048-2","volume":"46","author":"J Trefler","year":"2026","unstructured":"Trefler J, Pasierb A, Lech L, \u017byci\u0144ska K (2026) Lower total serum immunoglobulin G is associated with impaired patient-reported health-related quality of life in systemic sclerosis: a prospective cross-sectional study. Rheumatol Int 46:3. https:\/\/doi.org\/10.1007\/s00296-025-06048-2","journal-title":"Rheumatol Int"},{"key":"6299_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00296-026-06198-x","volume":"46","author":"M Erdo\u011fan Soysal","year":"2026","unstructured":"Erdo\u011fan Soysal M, Turk I, \u00d6zdo\u011fan Bircan A, Soysal M (2026) Clinical and psychosocial determinants of oral handicap in systemic sclerosis: a cross-sectional study. Rheumatol Int 46:159. https:\/\/doi.org\/10.1007\/s00296-026-06198-x","journal-title":"Rheumatol Int"},{"key":"6299_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/ard-2023-224416","volume":"83","author":"I Parodis","year":"2024","unstructured":"Parodis I, Girard-Guyonvarc\u2019h C, Arnaud L et al (2024) EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann Rheum Dis 83:720\u2013729. https:\/\/doi.org\/10.1136\/ard-2023-224416","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06299-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:06:16Z","timestamp":1793016376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06299-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["6299"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06299-7","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"26 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest related to this work.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Generative artificial intelligence (ChatGPT, GPT-5.6 Sol, OpenAI) was used during May\u2013June 2026 for English-language editing and to improve the clarity and readability of the manuscript. All AI-assisted text was critically reviewed, verified, and revised by the authors. The authors take full responsibility for the accuracy, integrity, and final content of the manuscript. Generative AI was not used for data generation, statistical analysis, or scientific interpretation of the study findings.","order":2,"name":"Ethics","label":"Use of generative artificial intelligence","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external commercial editing agency, professional language-editing service, or commercial editing support was used in the preparation of this manuscript.","order":3,"name":"Ethics","label":"External editing support","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No part of the scientific data, analyses, or study findings in this report was copied from or published elsewhere, and no scientific content or study results were generated by AI. As disclosed above, generative AI was used only for language editing; all AI-assisted wording was critically reviewed and revised by the authors.","order":4,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"262"}}